Cargando…

Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes

IMPORTANCE: Evidence on the effectiveness and safety of COVID-19 therapies across a diverse population with varied risk factors is needed to inform clinical practice. OBJECTIVE: To assess the safety of neutralizing monoclonal antibodies (nMAbs) for the treatment of COVID-19 and their association wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrose, Nalini, Amin, Alpesh, Anderson, Brian, Barrera-Oro, Julio, Bertagnolli, Monica, Campion, Francis, Chow, Daniel, Danan, Risa, D’Arinzo, Lauren, Drews, Ashley, Erlandson, Karl, Fitzgerald, Kristin, Garcia, Melissa, Gaspar, Fraser W., Gong, Carlene, Hanna, George, Jones, Stephen, Lopansri, Bert, Musser, James, O’Horo, John, Piantadosi, Steven, Pritt, Bobbi, Razonable, Raymund R., Roberts, Seth, Sandmeyer, Suzanne, Stein, David, Vahidy, Farhaan, Webb, Brandon, Yttri, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126875/ https://www.ncbi.nlm.nih.gov/pubmed/37093599 http://dx.doi.org/10.1001/jamanetworkopen.2023.9694

Ejemplares similares

1120. Reliability of Parent-Reported Pediatric Antibiotic Use in a Longitudinal Birth Cohort
por: D’Arinzo, Lauren, et al.
Publicado: (2019)

290. Hepatitis E Virus Serostatus: A Retrospective Assessment of Demographics and Comorbidities to Assess High-risk Populations
por: Stone, Eric C, et al.
Publicado: (2019)

Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
por: Yetmar, Zachary A, et al.
Publicado: (2022)

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)

Imported Haycocknema perplexum Infection, United States
por: Pritt, Bobbi S., et al.
Publicado: (2022)

An external stability audit framework to test the validity of personality prediction in AI hiring
por: Rhea, Alene K., et al.
Publicado: (2022)

Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch
por: Razonable, Raymund R, et al.
Publicado: (2022)

Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population
por: Tannous, Jonika, et al.
Publicado: (2023)

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
por: O’Horo, John, et al.
Publicado: (2022)

A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke
por: Potter, Thomas B. H., et al.
Publicado: (2022)

Histopathology of viral infections of the lung
por: Pritt, Bobbi S., et al.
Publicado: (2017)

Cyclosporiasis—Updates on Clinical Presentation, Pathology, Clinical Diagnosis, and Treatment
por: Mathison, Blaine A., et al.
Publicado: (2021)

Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
por: Razonable, Raymund R.
Publicado: (2011)

Risk factors for severity of COVID-19 in hospital patients age 18–29 years
por: Sandoval, Micaela, et al.
Publicado: (2021)

Uncommon Cause of Emesis and Diarrhea in a Nonverbal Elderly Patient
por: Rozenova, Krasimira, et al.
Publicado: (2021)

871. Clinical Detection of Intestinal Protozoa in Digitized Modified Trichrome-Stained Stool Specimens using a Deep Convolutional Neural Network Assisted Workflow
por: Morris, Heather Rose, et al.
Publicado: (2023)

Cytomegalovirus Infections in Solid Organ Transplantation: A Review
por: Ramanan, Poornima, et al.
Publicado: (2013)

1565. Lymphocyte Subsets as Predictors of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Dhand, Abhay, et al.
Publicado: (2022)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
por: Kasten, Mary J., et al.
Publicado: (2023)

Histopathologic review of granulomatous inflammation
por: Shah, Kabeer K., et al.
Publicado: (2017)

Human Botfly Infestation in an Amerindian Girl in Southern Venezuela
por: Gabaldon-Figueira, Juan C., et al.
Publicado: (2021)

344. Demographics of Patients with Brain Abscesses: A 10-year Mayo Clinic-Multicenter-Based Population Descriptive Study
por: Campioli, Cristina G Corsini, et al.
Publicado: (2020)

Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus
por: Melendez, Dante P, et al.
Publicado: (2015)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

1536. Donor-Derived Mycobacterium tuberculosis Infection After Solid-Organ Transplantation: A Comprehensive Review
por: Abad, Cybele Lara, et al.
Publicado: (2018)

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
por: El Helou, Guy, et al.
Publicado: (2019)

Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update
por: Abad, Cybele L., et al.
Publicado: (2016)

Stewardship of COVID-19 volunteers by nested trial design
por: Gottlieb, Robert L, et al.
Publicado: (2022)

Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
por: O’Horo, John C., et al.
Publicado: (2022)

Critical Care Viral Infections
por: O'Horo, John C., et al.
Publicado: (2019)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

Cutaneous myiasis in an elderly woman in Somaliland()()
por: Yusuf, Mukhtar A., et al.
Publicado: (2019)

Endemic bot fly larvae infection in Northern New York State
por: Hale, Andrew J., et al.
Publicado: (2019)

Direct Kidney Involvement by Tropherymawhipplei
por: Mignano, Salvatore E., et al.
Publicado: (2023)

Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
por: Venkatakrishnan, A. J., et al.
Publicado: (2023)

1552. Absolute Lymphocyte Threshold: A Simple Readily Available Tool to Predict Risk of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0gbpdaslmfcqo72bc4fu89l86c